Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
SQZ Biotechnologies is a clinical-stage biotechnology company focused on developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. The company's proprietary Cell Squeeze® technology enables the physical squeezing of cells through a microfluidic chip, temporarily disrupting the cell membrane to deliver a wide variety of therapeutic cargos, such as mRNA, DNA, proteins, and siRNAs, into the cells with minimal impact on cell health and function. SQZ aims to leverage this platform to create a new generation of cell therapies that can harness the power of a patient's own immune system to fight disease. The company has recently undergone significant restructuring to focus its resources on its most promising programs.
Serves as the central hub for research and development, corporate operations, clinical development, and strategic decision-making.
Modern laboratory and office facilities located within the Arsenal Yards, a contemporary mixed-use development. The facilities are designed to support advanced cell therapy research and manufacturing process development.
Historically a dynamic, science-driven, and innovative environment. Recent restructuring may have shifted the culture, but the core likely remains focused on scientific excellence and patient impact, albeit with a smaller, more focused team.
The Watertown headquarters is strategically positioned within a leading biotech ecosystem, facilitating access to talent, research collaborations, and industry partnerships.
SQZ Biotechnologies' physical operations are primarily concentrated at its headquarters in Watertown, Massachusetts, USA. While they may engage in global collaborations for clinical trials and research partnerships, they do not maintain significant independent office locations outside of their main HQ. Their focus is on advancing their cell therapy platform and clinical programs, which may involve international sites for trials.
200 Arsenal Yards Blvd, Suite 210
Watertown
MA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, SQZ Biotechnologies' leadership includes:
SQZ Biotechnologies has been backed by several prominent investors over the years, including:
SQZ Biotechnologies has undergone significant leadership changes and restructuring in the past 12-18 months, including CEO transition, CFO appointment, and departures of several key executives as part of its strategic realignment.
Discover the tools SQZ Biotechnologies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
SQZ Biotechnologies likely uses common corporate email formats. Based on typical patterns and executive contact information, the most probable format is firstinitiallast@sqzbiotech.com.
[first_initial][last]@sqzbiotech.com
Format
hbernstein@sqzbiotech.com
Example
80%
Success rate
GlobeNewswire • April 8, 2024
SQZ Biotechnologies announced it received a delinquency letter from Nasdaq due to not timely filing its Annual Report on Form 10-K for the year ended December 31, 2023. The company has 60 days to submit a plan to regain compliance....more
GlobeNewswire • November 13, 2023
SQZ Biotechnologies provided updates on its strategic priorities, including focusing on the SQZ® eAPC and TAC programs. The company also reported its Q3 2023 financial results and announced the appointment of David First as CFO....more
GlobeNewswire • August 14, 2023
SQZ Biotechnologies announced a strategic prioritization of its clinical programs and a corresponding workforce reduction of approximately 60%, to approximately 15 full-time employees. Founder and CEO Armon Sharei transitioned to a scientific advisory role, with CMO Howard Bernstein appointed Interim CEO....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including SQZ Biotechnologies, are just a search away.